Friday, June 19, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 905 of 1,261
  1. US 8273868

    Compositions and methods for inhibiting viral replication

    Alnylam Pharmaceuticals, Inc. · Granted Sep 25, 2012 · Expires Sep 20, 2032

    granted
  2. US 8273339

    Polymer-based compositions and conjugates of antimicrobial agents

    Nektar Therapeutics · Granted Sep 25, 2012 · Expires Sep 20, 2032

    granted
  3. US 8273833

    Branched Polymers

    Nektar Therapeutics · Granted Sep 25, 2012 · Expires Sep 20, 2032

    granted
  4. US 8273780

    Polycyclic antagonists of lysophosphatidic acid receptors

    AMIRA PHARMACEUTICALS, INC. · Granted Sep 25, 2012 · Expires Sep 20, 2032

    granted
  5. US 8273894

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Sep 25, 2012 · Expires Sep 20, 2032

    granted
  6. US 8268825

    Method for the treatment of anthrax infections

    The Board of Regents for Oklahoma State University · Granted Sep 18, 2012 · Expires Sep 13, 2032

    granted
  7. US 8268792

    Use of an active ingredient combination that contains hydroxystilbene for preventing and/or treating diseases

    Reinhard Rettenberger · Granted Sep 18, 2012 · Expires Sep 13, 2032

    granted
  8. US 8268873

    Inhibitors of IMPDH enzyme

    Vertex Pharmaceuticals Incorporated · Granted Sep 18, 2012 · Expires Sep 13, 2032

    granted
  9. US 8268615

    Expression, purification and uses of a plasmodium falciparum liver stage antigen 1 polypeptide

    The United States of America as represented by the Secretary of the Army · Granted Sep 18, 2012 · Expires Sep 13, 2032

    granted
  10. US 8269026

    Lupane derivatives useful for treating HIV

    Vertex Pharmaceuticals Incorporated · Granted Sep 18, 2012 · Expires Sep 13, 2032

    granted
  11. US 8269012

    Aminopyrazole triazolothiadiazole inhibitors of c-met protein kinase

    Vertex Pharmaceuticals Incorporated · Granted Sep 18, 2012 · Expires Sep 13, 2032

    granted
  12. US 8268999

    Tri-cyclic pyrazolopyridine kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Sep 18, 2012 · Expires Sep 13, 2032

    granted
  13. US 8268894

    Compositions and methods for the treatment of infectious diseases

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 18, 2012 · Expires Sep 13, 2032

    granted
  14. US 8268890

    Method of treating ischemia/reperfusion injury with nitroxyl donors

    The United States of America, as represented by the Secretary, Health and Human Services · Granted Sep 18, 2012 · Expires Sep 13, 2032

    granted
  15. US 8269013

    Substituted pyrazole inhibitors of c-Met protein kinase

    Vertex Pharmaceuticals Incorporated · Granted Sep 18, 2012 · Expires Sep 13, 2032

    granted
  16. US 8268863

    Disubstituted alkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

    Theravance, Inc. · Granted Sep 18, 2012 · Expires Sep 13, 2032

    granted
  17. US 8268849

    Multifunctional Antioxidants and methods of use thereof

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Sep 18, 2012 · Expires Sep 13, 2032

    granted
  18. US 8268829

    Substituted pyrimidines useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Sep 18, 2012 · Expires Sep 13, 2032

    granted
  19. US 8268851

    Compositions and methods for inhibition of the JAK pathway

    Rigel Pharmaceuticals, Inc. · Granted Sep 18, 2012 · Expires Sep 13, 2032

    granted
  20. US 8268819

    Hexahydrooxazinopterine compounds

    Takeda Pharmaceutical Company Limited · Granted Sep 18, 2012 · Expires Sep 13, 2032

    granted
  21. US 8268818

    Inhibitors of C-MET and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Sep 18, 2012 · Expires Sep 13, 2032

    granted
  22. US 8268811

    Thiazoles and pyrazoles useful as kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Sep 18, 2012 · Expires Sep 13, 2032

    granted
  23. US 8268786

    Anti-cancer tocotrienol analogues and associated methods

    First Tech International Limited · Granted Sep 18, 2012 · Expires Sep 13, 2032

    granted
  24. US 8268777

    Oximyl macrocyclic derivatives

    Enanta Pharmaceuticals, Inc. · Granted Sep 18, 2012 · Expires Sep 13, 2032

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.